Obesity, but not ethanol, promotes tumor incidence and progression in a mouse model of hepatocellular carcinoma in vivo

Surgical Endoscopy

Volumn 27, Issue 8, 2013, Pages 2782-2791

  Thompson, Kyle J ^a   Swan, Ryan Z ^a   Walling, Tracy L ^a   Iannitti, David A ^a   McKillop, Iain H ^a   Sindram, David ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Ethanol; Hepatocellular carcinoma; Leptin; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ASPARTATE AMINOTRANSFERASE; DIETHYLNITROSAMINE; DRINKING WATER; GLUTATHIONE; GLUTATHIONE DISULFIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CANCER GROWTH; CANCER INCIDENCE; CANCER SIZE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; ENZYME ANALYSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER INJURY; LIVER LEVEL; LIVER PARENCHYMA; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; NUTRITIONAL STATUS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISEASE PROGRESSION; ETHANOL; INCIDENCE; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; OBESITY; RISK FACTORS;

EID: 84881369257     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-013-2808-8     Document Type: Article

References (38)

1. McKillop IH, Moran DM, Jin X, Koniaris LG (2006) Molecular pathogenesis of hepatocellular carcinoma. J Surg Res 136:125-135
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
3. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245-1255
4. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578
5. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16:2533-2547
6. Bracci PM (2012) Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog 51:53-63
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638
8. Schlesinger S, Aleksandrova K, Pischon T, Fedirko V, Jenab M, Trepo E, Boffetta P, Dahm CC, Overvad K, Tjonneland A, Halkjaer J, Fagherazzi G, Boutron-Ruault MC, Carbonnel F, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Bamia C, Lagiou P, Palli D, Grioni S, Panico S, Tumino R, Vineis P, Hb BD, van den Berg S, Peeters PH, Braaten T, Weiderpass E, Quiros JR, Travier N, Sanchez MJ, Navarro C, Barricarte A, Dorronsoro M, Lindkvist B, Regner S, Werner M, Sund M, Khaw KT, Wareham N, Travis RC, Norat T, Wark PA, Riboli E, Nothlings U (2013) Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 132(3):645-657
9. Yuan JM, Govindarajan S, Arakawa K, Yu MC (2004) Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US. Cancer 101:1009-1017
10. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42:218-224
11. Schattenberg JM, Schuppan D (2011) Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. Curr Opin Lipidol 22:479-488
12. Bellentani S, Marino M (2009) Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol 8(suppl 1):S4-S8
13. Chitturi S, Wong VW, Farrell G (2011) Nonalcoholic fatty liver in Asia: firmly entrenched and rapidly gaining ground. J Gastroenterol Hepatol 26(suppl 1):163-172
14. Hill-Baskin AE, Markiewski MM, Buchner DA, Shao H, DeSantis D, Hsiao G, Subramaniam S, Berger NA, Croniger C, Lambris JD, Nadeau JH (2009) Diet-induced hepatocellular carcinoma in genetically predisposed mice. Hum Mol Genet 18:2975-2988
15. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140:197-208
16. Brandon-Warner E, Walling TL, Schrum LW, McKillop IH (2012) Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res 36:641-653
17. Karaa A, Thompson KJ, McKillop IH, Clemens MG, Schrum LW (2008) S-adenosyl-l-methionine attenuates oxidative stress and hepatic stellate cell activation in an ethanol-LPS-induced fibrotic rat model. Shock 30:197-205
18. Loomba R, Yang HI, Su J, Brenner D, Iloeje U, Chen CJ (2010) Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. Clin Gastroenterol Hepatol 8:891-898
19. Brandon-Warner E, Eheim AL, Foureau DM, Walling TL, Schrum LW, McKillop IH (2012) Silibinin (milk thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice. Cancer Lett 326(1):88-95
20. Zimmers TA, Jin X, Gutierrez JC, Acosta C, McKillop IH, Pierce RH, Koniaris LG (2008) Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. J Cancer Res Clin Oncol 134:753-759
21. Lakner AM, Walling TL, McKillop IH, Schrum LW (2011) Altered aquaporin expression and role in apoptosis during hepatic stellate cell activation. Liver Int 31:42-51
22. El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365:1118-1127
23. Kushida M, Kamendulis LM, Peat TJ, Klaunig JE (2011) Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice. Toxicol Pathol 39:776-786
24. Yoneyama N, Crabbe JC, Ford MM, Murillo A, Finn DA (2008) Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol 42:149-160
25. Brandon-Warner E, Schrum LW, Schmidt CM, McKillop IH (2012) Rodent models of alcoholic liver disease: of mice and men. Alcohol 46(8):715-725
26. Thompson KJ, Swan RZ, Iannitti DA, McKillop IH, Sindram D (2013) Diet-induced obesity and ethanol impair progression of hepatocellular carcinoma in a mouse mesenteric vein injection model. Surg Endosc 27(1):246-255
27. Zhang Y, Scarpace PJ (2006) The role of leptin in leptin resistance and obesity. Physiol Behav 88:249-256
28. Sadik NA, Ahmed A, Ahmed S (2012) The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients. Hum Exp Toxicol 31:311-321
29. Sharma D, Wang J, Fu PP, Sharma S, Nagalingam A, Mells J, Handy J, Page AJ, Cohen C, Anania FA, Saxena NK (2010) Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology 52:1713-1722
30. Wang SN, Lee KT, Ker CG (2010) Leptin in hepatocellular carcinoma. World J Gastroenterol 16:5801-5809
31. Ribatti D, Belloni AS, Nico B, Di Comite M, Crivellato E, Vacca A (2008) Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma. Peptides 29:1596-1602
32. Barinaga M (1998) Leptin sparks blood vessel growth. Science 281:1582
33. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, Anania FA (2007) Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 67:2497-2507
34. Tartaglia LA (1997) The leptin receptor. J Biol Chem 272:6093-6096
35. Thompson KJ, Lau KN, Johnson S, Martinie JB, Iannitti DA, McKillop IH, Sindram D (2011) Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling. HPB (Oxford) 13:225-233
36. Behrend L, Henderson G, Zwacka RM (2003) Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31:1441-1444
37. Shimizu M, Sakai H, Shirakami Y, Yasuda Y, Kubota M, Terakura D, Baba A, Ohno T, Hara Y, Tanaka T, Moriwaki H (2011) Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice. Cancer Prev Res (Phila) 4:396-403
38. Heckley GA, Jarl J, Asamoah BO, GG U (2011) How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. BMC Cancer 11:446